RUSSIALINK: “Russia past peak of coronavirus epidemic – Rospotrebnadzor’s Epidemiology Institute” – Interfax

Covid-19 Coronavirus file photo, adapted from image at cdc.gov

MOSCOW. Jan 15 (Interfax) – It looks like Russia has passed the peak of the coronavirus epidemic, and there is currently a trend toward stabilization, Deputy Director of Rospotrebnadzor’s Central Research Institute of Epidemiology for Clinical Analysis Natalia Pshenichnaya said. “We’re observing a certain trend toward stabilization,” Pshenichnaya told journalists on Friday. “Daily morbidity may still fluctuate, considering that Russia […]

» Read more

JRL NEWSWATCH: “Russia struggles to distribute its vaccine to the regions; Putin calls for ‘mass’ inoculation as data suggest government is delivering fewer jabs than promised” – Financial Times/ Henry Foy

File Photo of Blue-Gloved Hand Holding Syringe and Injecting Arm, adapted from image at nih.gov

“… Russia’s government says 1.5m vaccines have been distributed … [with] hundreds of thousands more … ready … [but] doctors and officials … [indicate] a far bleaker reality of limited supplies and delayed shipments. … Moscow’s clinics have been busy vaccinating … [but] regions outside of the capital have struggled to secure adequate supplies, calling into question … [governmental] ability […]

» Read more

RUSSIALINK: “Pivotal moment approaching in coronavirus crisis, situation to start improving – PM Mishustin” – Interfax

Coronavirus File Photo adapted from image at cdc.gov

Russian Prime Minister Mikhail Mishustin is expecting the start of recovery from the socioeconomic crisis caused by the coronavirus pandemic […]

» Read more

Pandemic Pushing West to Cooperation and Reform But Russia to Reaction, Isolation, and Decay, Shevtsova Says

Covid-19 Coronavirus file photo, adapted from image at cdc.gov

Because of the pandemic, 2020 was “the year of the Apocalypse” for both Russia and the West, but the two responded in opposite ways[…]

» Read more

RUSSIALINK: “Most Small Businesses Still Struggling, Warns Top Business Lobby; Small companies twice as likely to be hit by pandemic” – Moscow Times

Cash, Calculator, Pen

Russia’s small companies [reportedly] were almost twice as likely to suffer negative consequences from the coronavirus pandemic than their larger counterparts […]

» Read more

JRL NEWSWATCH: “Why I Got the Russian Vaccine” – New York Times/ Andrew E. Kramer

File Photo of Blue-Gloved Hand Holding Syringe and Injecting Arm, adapted from image at nih.gov

“A New York Times reporter juggled fears engendered by the politicized rollout of the Sputnik V vaccine with the urge to gain protection from the deadly virus.” “… Russia’s coronavirus vaccine … Sputnik V[] [is] made at a factory outside of Moscow from genetically modified human cold viruses. Like so much else in Russia, … [its] rollout … was entangled […]

» Read more

JRL NEWSWATCH: “How Gamaleya’s Vaccine Works” – New York Times/ Jonathan Corum, Carl Zimmer

File Photo of Blue-Gloved Hand Holding Syringe and Injecting Arm, adapted from image at nih.gov

“The Gamaleya Research Institute, part of Russia’s Ministry of Health, developed a coronavirus vaccine known as Sputnik V or Gam-Covid-Vac. Gamaleya announced in December that the vaccine had an efficacy of 91.4 percent. Russia is using it in a mass vaccination campaign, and it is now being distributed in Argentina, Belarus and other countries ….” Click here for: “How Gamaleya’s […]

» Read more

Kremlin Must Start Now and Work Hard to Overcome Russian Resistance to Getting Immunized, Experts Say

File Photo of Blue-Gloved Hand Holding Syringe and Injecting Arm, adapted from image at nih.gov

(Paul Goble – Window On Eurasia – Staunton, Nov. 15, 2020) With the prospect that one or more vaccines against the coronavirus will be available in the near future, the Russian government must launch a massive effort to overcome the skepticism of Russians and get the vast majority of them to get the shots when they become available, experts say. […]

» Read more

Because of Pandemic, Moscow This Year Spent More on Economy than on Defense

Covid-19 Coronavirus file photo, adapted from image at cdc.gov

(Paul Goble – Window on Eurasia – Staunton, September 19, 2020) The pandemic has introduced major changes in Russian government policy but perhaps not one greater than this: for the first time in a very long time, the Russian government has spent more on promoting the economy than on maintaining and developing its military (sobkorr.org/news/5F6610F248362.html). The number of new cases […]

» Read more

JRL NEWSWATCH: “Russia Publishes Virus Vaccine Results, Weeks After Approval” – AP

Medical Symbol with Pole, Serpents, Wings, adapted from image at lanl.gov

“Russian scientists have belatedly published first results from early trials into the experimental Sputnik V vaccine, which received government approval last month but drew considerable criticism from experts, as the shots had only been tested on several dozen people before being more widely administered. In a [Lancet] report … [vaccine] developers … said it appeared to be safe and to […]

» Read more

RUSSIALINK: “Results of Sputnik V vaccine trials published in The Lancet” – Interfax

File Photo of Blue-Gloved Hand Holding Syringe and Injecting Arm, adapted from image at nih.gov

[Lancet: thelancet.com/journals/lancet/article/PIIS0140-6736(20)31866-3/fulltext] MOSCOW. Sept 4 (Interfax) – One of the world’s most reputable medical journals, The Lancet, has published the results of the Phase 1 and Phase 2 clinical trials of the Russian coronavirus vaccine Sputnik V, developed by the Gamaleya Institute. “The research being published in The Lancet proves the high level of safety and efficacy of the Russian […]

» Read more

RUSSIALINK: “Elderly Coronavirus Vaccine Recipients ‘Healthy,’ Russian Developer Says” – Moscow Times

File Photo of Blue-Gloved Hand Holding Syringe and Injecting Arm, adapted from image at nih.gov

(Moscow Times – themoscowtimes.com – Sept. 2, 2020) Elderly scientists who helped develop Russia’s Sputnik V coronavirus vaccine have not reported adverse effects after being injected, the head of the research institute behind the inoculation told the state-run RIA Novosti news agency Wednesday. Sputnik V’s registration last month as the world’s first coronavirus vaccine before large-scale clinical trials has sparked […]

» Read more

JRL NEWSWATCH: “Surreal scenes inside Russia’s battle against the pandemic” – National Geographic/ Nanna Heitmann

Covid-19 Coronavirus file photo, adapted from image at cdc.gov

“Patients continue to fill hospitals as rumours and cynicism spread about a vaccine.” “… [A]ll these [Moscow] hospitals [are now COVID-19 centres,] devoted to one disease that didn’t exist … months ago[] … shocking inside the hospitals. From the moment you’re in the elevator you’re in a ‘red zone’ … considered contaminated[,] [e]verywhere … a red zone[,] … nurses prepar[ing] […]

» Read more

JRL NEWSWATCH: “Russia Registers World’s First Covid-19 Vaccine Despite Safety Concerns” – Wall Street Journal/ Thomas Grove

Coronavirus File Photo adapted from image at cdc.gov

“Officials in Russia and the West express alarm at the speed the vaccine was developed.” “[With Putin’s blessing,] Russia registered the world’s first Covid-19 vaccine … amid [anticipation, skepticism and ] safety concerns …. Moscow’s [state-run] Gamaleya Institute for Epidemiology and Microbiology developed the vaccine … [with] military testing, accelerated clinical evaluations and shortened trial times …. Russia [plans] … […]

» Read more

JRL NEWSWATCH: “Industry Body Calls Russian Covid-19 Vaccine a Pandora’s Box” – Bloomberg/ Ilya Arkhipov, Jake Rudnitsky

Coronavirus File Photo adapted from image at cdc.gov

“Russia’s race to allow civilian use of a … coronavirus vaccine before clinical trials are complete could put people at risk, according to a local association of multinational pharmaceutical companies[, the Association of Clinical Trials Organizations (ACTO) … represent[ing] … multinational companies with clinical trials in Russia, including Pfizer, AstraZeneca and Novartis AG]. The government plans to give a vaccine […]

» Read more

JRL NEWSWATCH: “Russian COVID-19 Vaccine Approval Imminent, Source Says” – Reuters

Medical Symbol with Pole, Serpents, Wings, adapted from image at lanl.gov

“Russia’s first potential COVID-19 vaccine [reportedly] will win local regulatory approval in the first half of August and be administered to frontline health workers soon afterwards …. [Moscow] state research facility … Gamaleya Institute [] completed early human trials of the adenovirus-based vaccine this month and expects to begin large-scale trials in August. … The speed at which Russia is […]

» Read more

RUSSIALINK: “Russia Has a Vaccination Problem” – Moscow Times

Medical Symbol with Pole, Serpents, Wings, adapted from image at lanl.gov

(Moscow Times – themoscowtimes.com – EVAN GERSHKOVICH – September 28, 2018 – themoscowtimes.com/articles/russia-has-a-vaccine-problem-63017) The problems began only after Anastasia Dvoretskaya’s son turned one. Before, she says, he had been a healthy child. Then, during his second year, he came down with a nagging cough, then recurring throat infections, and then the flu. Up until that point, Dvoretskaya, 30, had vaccinated […]

» Read more

NEWSLINK: “Russia trolls ‘spreading vaccination misinformation’ to create discord” – BBC

Montage of Instagram, Twitter and Facebook Logos, adapted from image at nps.gov

“Troll accounts that had attempted to influence the US election had also been tweeting about vaccines, a study says. Many posted both pro- and anti-vaccination messages to create “false equivalency”, the study found. …”

» Read more